Noselab GmbH
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion (NCT05791552) | Noselab GmbH | 2022-02-15 |
Track Noselab GmbH automatically
Every clearance here is in the API, with alerts when new ones post.